Equity · Healthcare
ACHV
NASDAQAchieve Life Sciences (ACHV)
The line runs 6.67 USD on 12 August through 6.79 USD on 9 November, on a scale from 6 to 9. Days the market did not trade hold the previous close, flat.
- Market cap
- 698.7M USD
- EPS, diluted, year to Dec 2025
- −1.25 USD
- 52-week range
- 2.65 USD – 8.54 USD
- Avg volume
- 82.3K
as of Nov 9, 2026
Have Achieve Life Sciences (ACHV) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Achieve Life Sciences insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 4 Dec 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 19 Aug 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 19 Aug 2026 | Stewart Richard AlistairDirector | Sell | 20,626 | 175K USD |
Which funds hold Achieve Life Sciences (ACHV)?
4 of the 45 institutional funds we track reported a Achieve Life Sciences position for the quarter ended 30 Jun 2026 — a combined 29.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Added | 3,770,313 | 24.6M USD | +269.9% |
| Two Sigma Investments | Trimmed | 441,187 | 2.9M USD | −25.0% |
| Renaissance Technologies | Added | 178,049 | 1.2M USD | +537.0% |
| Citadel Advisors | New position | 123,129 | 804K USD | |
| Millennium Management | Exited | |||
| Point72 Asset Management | Exited |
What has been filed or recorded for Achieve Life Sciences (ACHV)?
The filings we hold for Achieve Life Sciences, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 60,286 shares | 422K USD notional · 0.059% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 59,403 shares | 419K USD notional · 0.058% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,290 shares | 9K USD notional · 0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 16,340 shares | 118K USD notional · 0.016% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 172,138 shares | 1.3M USD notional · 0.167% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 206,700 shares | 1.7M USD notional · 0.201% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 17,790 shares | 137K USD notional · 0.017% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 7,050 shares | 53K USD notional · 0.007% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.80 USD | |
| 30 Jun 2026 | Financials | Total assets | 190.4M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −14.7M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.19 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.25 USD | |
| 31 Dec 2025 | Financials | Net income | −54.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.25 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.28 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.37 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.37 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.24 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.36 USD |
What do people ask about Achieve Life Sciences (ACHV)?
What did Achieve Life Sciences shares close at?6.79
Achieve Life Sciences closed at 6.79 USD on 9 Nov 2026, up 1.04% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Achieve Life Sciences’ market cap?698.7M
Achieve Life Sciences is worth 698.7M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
Have Achieve Life Sciences insiders bought or sold shares recently?1 sale
In the 90 days to 10 Nov 2026, Achieve Life Sciences insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 4 Dec 2025, show no open-market purchase. See Insiders
Which funds own Achieve Life Sciences?4 of 45
4 of the 45 funds we track reported a Achieve Life Sciences position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace, Two Sigma Investments and Renaissance Technologies. See Funds
When did Achieve Life Sciences last report earnings?−0.80
Achieve Life Sciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.80 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings